
Douglas Flora: America Is Abandoning One of the Greatest Medical Breakthroughs
Douglas Flora, President-Elect Association of Cancer Care Centers at Association of Cancer Care Centers, shared on LinkedIn:
“America Is Abandoning One of the Greatest Medical Breakthroughs
‘Political narratives about mRNA have fueled confusion, which leads to mistrust, yet the scientific evidence consistently shows that this technology is safe and effective and holds enormous potential for future vaccines and treatments. Some have claimed mRNA encourages viral mutations or prolongs pandemics. Research says otherwise. Mutations arise when viruses replicate. Vaccination can help reduce the chances of virus replication, which would reduce opportunities for mutation.’
This quote perfectly captures the core issue we’re facing. While the public discourse around mRNA technology has been challenging, the scientific community continues to quietly make monumental strides, particularly in the field of oncology.
The true potential of mRNA extends far beyond infectious diseases. Researchers and clinicians are now using it to develop personalized cancer therapies. Instead of a one-size-fits-all approach, these new therapies are designed to train a patient’s own immune system to specifically identify and attack their cancer cells.
This isn’t a future-tense idea; it’s happening right now. There are over 120 clinical trials underway for a range of cancers, including melanoma, pancreatic, and brain tumors. We’ve already seen encouraging data from trials showing a significant reduction in recurrence when mRNA therapies are combined with existing treatments.
The promise of this technology is immense. By focusing on the scientific facts and what’s being discovered at the front lines of care, we can ensure we continue to advance medical innovation for our patients and communities.
Thanks, Eric Topol, MD for helping spread the word. I’d have missed this important editorial had you not shared on Ground Truths.”
More posts featuring Douglas Flora.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023